This study is testing a new communication tool called the Collaborative Agenda-Setting Intervention (CASI) for people with ovarian cancer, their caregivers, and their doctors. CASI aims to improve how patients and doctors talk to each other, help set discussion topics for clinic visits, encourage talking about emotional and social concerns, and potentially reduce stress for doctors. This is a pilot study, meaning it's the first time researchers are testing CASI. To join, you must be at least 18 years old, speak English, be willing to have your clinic visits audio recorded, and have advanced ovarian cancer (stage III, stage IV, or recurrent disease). The main goal of this study is to see how many people enroll.

Study design

This is a pilot feasibility study with two groups. Up to 112 people are expected to participate, including up to 50 patients, 50 caregivers, and 12 clinicians.

What's involved

You would have audio-recorded clinic visits and complete questionnaires. Your participation is expected to last up to 12 weeks.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.